Celecoxib
Brand name: Celecoxib
Rank #188 of 500 drugs by total cost
$77.7M
Total Cost
1,938,505
Total Claims
$77.7M
Total Cost
49,891
Prescribers
$40
Cost per Claim
517,820
Beneficiaries
3,127,826
30-Day Fills
$1,556
Avg Cost/Provider
39
Avg Claims/Provider
About Celecoxib
Celecoxib (sold as Celecoxib) was prescribed 1,938,505 times by 49,891 Medicare Part D providers in 2023, costing the program $77.7M. At $40 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
| 188 | Celecoxib (Celecoxib) | $77.7M | 1,938,505 |
| 189 | Sod Phenylbutyrat/Taurursodiol (Relyvrio) | $77.0M | 6,152 |
| 190 | Pravastatin Sodium (Pravastatin Sodium) | $76.8M | 4,033,829 |
| 191 | Lanadelumab-Flyo (Takhzyro) | $76.5M | 1,670 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology